Diabetes mellitus among HIV-infected individuals in follow-up care at University of Gondar Hospital, Northwest Ethiopia

被引:27
作者
Abebe, Solomon Mekonnen [1 ]
Getachew, Assefa [2 ]
Fasika, Solomon [2 ]
Bayisa, Mulugeta [2 ]
Demisse, Abayneh Girma [2 ]
Mesfin, Nebiyu [2 ]
机构
[1] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia
[2] Univ Gondar, Sch Med, Coll Med & Hlth Sci, Gondar, Ethiopia
来源
BMJ OPEN | 2016年 / 6卷 / 08期
关键词
INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; PREVALENCE; IMPACT; LIPODYSTROPHY; OBESITY; TB;
D O I
10.1136/bmjopen-2016-011175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the prevalence of diabetes mellitus (DM) and associated factors among HIV-infected adults in northwest Ethiopia. Design: Hospital-based cross-sectional study. Setting: HIV clinic of the University of Gondar Hospital, Ethiopia. Participants: All HIV-infected adults who visited the HIV clinic from December 2013 to the end of February 2014 were the source population. Measures: A structured and pretested questionnaire incorporating the WHO STEPwise approach was used. A multivariate logistic regression analysis was applied to assess factors associated with DM. Results: The overall prevalence of type 2 DM was 8% (95% CI 5.5% to 10.5%). The prevalence of DM was higher (13.2%; 95% CI 8.0% to 18.3%) among subjects receiving pre-antiretroviral treatment (pre-ART) than among those taking ART (5.1%; 95% CI 2.6% to 7.6%). Thirteen (35.1%) of the DM cases were newly identified during the study. Obesity (adjusted OR (AOR) 6.55; 1.20 to 35.8), hypertension (AOR 3.45; 1.50 to 7.90), being in the pre-ART group (AOR 4.47; 1.80 to 11.08), hypertriglyceridaemia (AOR 2.24; 1.02 to 49.5) and tertiary-level education (AOR 11.8; 2.28 to 61.4) were associated with DM. Conclusions: Overall DM prevalence was high, particularly among subjects in the pre-ART group. More educated, hypertensive and obese HIV-infected adults were more likely to have DM as a comorbidity. Health policy and the clinical management of HIV-infected individuals should take into account the rising DM.
引用
收藏
页数:6
相关论文
共 23 条
  • [1] [Anonymous], 2011, GLOB HIV AIDS RESP E
  • [2] Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs
    Araujo, Susana
    Banon, Sara
    Machuca, Isabel
    Moreno, Ana
    Perez-Elias, Maria J.
    Casado, Jose L.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (05) : 545 - 554
  • [3] Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
    Behrens, G
    Dejam, A
    Schmidt, H
    Balks, HJ
    Brabant, G
    Körner, T
    Stoll, M
    Schmidt, RE
    [J]. AIDS, 1999, 13 (10) : F63 - F70
  • [4] Clinical impact of HIV-related lipodystrophy and metabolic abnormalities on cardiovascular disease
    Behrens, GMN
    Meyer-Olson, D
    Stoll, M
    Schmidt, RE
    [J]. AIDS, 2003, 17 : S149 - S154
  • [5] Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study
    Carr, A
    Samaras, K
    Thorisdottir, A
    Kaufmann, GR
    Chisholm, DJ
    Cooper, DA
    [J]. LANCET, 1999, 353 (9170) : 2093 - 2099
  • [6] Abdominal obesity and metabolic syndrome
    Despres, Jean-Pierre
    Lemieux, Isabelle
    [J]. NATURE, 2006, 444 (7121) : 881 - 887
  • [7] Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome
    Grinspoon, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 : S85 - S90
  • [8] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, R
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Cleeman, JI
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    Keller, SA
    Jehle, AJ
    [J]. CIRCULATION, 2002, 106 (25) : 3143 - 3421
  • [9] Grundy SM, 2004, CIRCULATION, V109, P433, DOI [10.1161/01.CIR.0000111245.75752.C6, 10.1161/01.CIR.0000112379.88385.67]
  • [10] LIPIDS, LIPOPROTEINS, TRIGLYCERIDE CLEARANCE, AND CYTOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    GRUNFELD, C
    PANG, MY
    DOERRLER, W
    SHIGENAGA, JK
    JENSEN, P
    FEINGOLD, KR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) : 1045 - 1052